Navigation Links
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
Date:8/6/2009

compounds.
  • On April 21, InterMune reported that the INFORM-1 study had been expanded by three additional cohorts to explore the interferon-free regimen in treatment-experienced patients, both treatment failures and null-responder HCV patients, and would include twice-daily dosing of ITMN-191 and significantly higher total daily doses (600mg and 900mg twice daily) than those explored in the first four patient cohorts.
  • Today the company announced that results of all seven cohorts of INFORM-1 will be presented in Presidential Plenary Session III (#193) at the 2009 AASLD meeting at 8:00 a.m. on November 3. The company also announced today that two additional abstracts on the topics of the PK/PD profile (#1594) and the viral resistance profile (#1585) of the INFORM-1 regimen have been accepted for poster presentations at the 2009 AASLD meeting, also on November 3.
  • 2009 Key Project Guidance

    The company provided the following guidance on its key development projects, pirfenidone and ITMN-191.

        Milestones And Key Events                              Expected Date
        -------------------------                              -------------
        Pirfenidone
        -----------
        Oral presentation on pirfenidone at ERS              September 14, 2009
        ---------------------------------------              ------------------
        Submission of pirfenidone NDA to FDA                            Q4 2009
        ------------------------------------                            -------
        Submission of pirfenidone MAA to EMEA                           Q1 2010
        -------------------------------------                           -------
    
        ITMN-191 (R7227)
        ---------------
        Phase 2b initiation by Roche ($20 million payment
         to InterMune)                                              August 2009
        -------------------------------------------------       
    '/>"/>
    SOURCE InterMune, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related biology technology :

    1. InterMune to Release Second Quarter Financial Results on August 6
    2. InterMune to Present at Goldman Sachs Healthcare Conference
    3. InterMune Reports First Quarter 2009 Financial Results and Business Highlights
    4. InterMune to Release First Quarter Financial Results on April 30
    5. InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25
    6. InterMune to Present at Canaccord Adams Hepatitis C Conference
    7. InterMune to Present at Citis 4th Annual Biotech Day
    8. InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting
    9. InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
    10. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
    11. InterMune Announces Issuance of U.S. Patent for ITMN-191
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... BioPharma Inc. (NASDAQ: ARRY ) today announced ... Pharma AG to acquire worldwide rights to encorafenib (LGX818), ... agreement is conditional on the closing of transactions announced by ... are expected to close in the first half of ...
    (Date:1/22/2015)...  Transwestern | RBJ today announces the firm brokered a long-term ... a leading biopharmaceutical company, at Two Ledgemont Center in ... Richards , president, and Brian Cohen , senior vice ... building at 95 Hayden Ave. Photo - ...
    (Date:1/22/2015)... January 22, 2015 The laboratory information ... has witnessed a number of technological advancements due to ... requirements, growing need to integrate healthcare systems, and increasing ... challenges in system integration. Key players in the market ...
    (Date:1/22/2015)... Boston, MA (PRWEB) January 22, 2015 ... systems, is pleased to announce an exciting product from a ... of motion analysis solutions over the past 15 years, with ... industries. Most recently, their 3D IMU system (inertial measurement unit), ...
    Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2
    ... DIEGO, Jan. 12, 2011 Sequenom (Nasdaq: ... in the British Medical Journal (BMJ 2011;342:c7401) of a ... Dennis Lo of The Chinese University of Hong Kong. ... present paper is the first report of a large-scale ...
    ... The VWR Charitable Foundation, in partnership with VWR ... distribution company, hosted an auction last night at the ... to benefit the Orlando Science Center. "Everyday, ... scientific explorers, and creates a hands-on experience that fosters ...
    ... Regenicin, Inc. (OTC Bulletin Board: RGIN ) ... cell therapies to restore the health of damaged tissues ... at the Sir Francis Drake Hotel in San Francisco ... present Regenicin,s core business model and strategic approach for ...
    Cached Biology Technology:Professor Dennis Lo Trisomy 21 Clinical Validation Study Published in British Medical Journal 2VWR Charitable Foundation to Support the Orlando Science Center with Auction 2VWR Charitable Foundation to Support the Orlando Science Center with Auction 3Regenicin CEO to Participate in Live Webcast at OneMedForum Business Development and Finance Conference, January 11th at 4:00 PM PST 2
    (Date:1/22/2015)... 2015   EyeLock, Inc. , a market leader of iris-based ... Gerber to the new role of Senior Vice President ... development of mobile platforms and wearable solutions for EyeLock,s technologies. ... in the semiconductor industry to his role at EyeLock, with ...
    (Date:12/22/2014)... DENVER , Dec. 22, 2014  The 2014 Holiday ... industry as Acuity Market Intelligence reports that the long ... Acuity forecasts that intensifying demand for smart phones, tablets, ... a global market of 2.5 billion users with nearly ...
    (Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button Synaptics ... http://photos.prnewswire.com/prnh/20130307/600769 ... iPhone 5S, Samsung introduces for the first time a ...
    Breaking Biology News(10 mins):EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
    ... (UC) researchers have received a grant in excess of $2 ... to determine the ideal time to fly that minimizes health ... them from the battlefield into a safe zone. ... soldiers to a cleaner, safer environment," explains Col. Warren Dorlac, ...
    ... . Within the last few years the number ... been increased considerably. A worthwhile effort as, after all, it ... methods of transport checks are offered by terahertz radiation. Before ... has to be measured quantitatively, so that damage to health ...
    ... producing significant amounts of a chemical form of aspirin, ... National Center for Atmospheric Research (NCAR), opens up new ... their impacts on air quality, and it also has ... about crops that are failing. "Unlike humans, who ...
    Cached Biology News:US Air Force grant targets medical evacuation procedures 2US Air Force grant targets medical evacuation procedures 3US Air Force grant targets medical evacuation procedures 4Checking people at airports -- with terahertz radiation 2Plants in forest emit aspirin chemical to deal with stress; discovery may help agriculture 2Plants in forest emit aspirin chemical to deal with stress; discovery may help agriculture 3
    Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
    Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
    Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
    PPIF Antibody...
    Biology Products: